Tanggot, Juven A.

HRN: 28-61-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/06/2026
03/13/2026
IV
45mg LD; 23mg MD
Q24
Sepsis
Checking Initial Appropriateness 

 Indication:  EmpiricEmpirical Escalation    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines